Sustained high incidence of pertussis, particularly amongst unvaccinated infants, is of
concern. Inclusion of pertussis vaccination with tetanus and low dose diphtheria (Td) …

Background Multivalent vaccines containing whole-cell pertussis (wP) antigens combined
with established diphtheria (D), tetanus (T), hepatitis B (HB), Haemophilus influenzae type b …

Objective. Diphtheria, tetanus and pertussis serum antibody titers were assessed before a
fifth dose of diphtheria-tetanus-acellular pertussis (DTaP) or diphtheria-tetanus-whole cell …

Booster vaccination with a reduced-antigen-content dTpa, pediatric DTPa or adult Td
vaccine in DTPa-primed children aged 4-6 years was evaluated. Immunogenicity and CMI …

[Immunogenicity and reactogenicity of a reduced antigen content diphtheria, tetanus and
acellular pertussis vaccine dTpa) in 10 to 11 years old children and in adults]. - Abstract - Europe …

Annual vaccination with trivalent influenza vaccine (TIV), and a single dose of tetanus toxoid-
reduced diphtheria toxoid-acellular pertussis (Tdap) vaccine, are both recommended for …

Reduced-antigen-content pertussis vaccines designed initially for booster vaccination of
adolescents and adults can also be used to vaccinate pre-school age children. Combination …

OBJECTIVE: To evaluate antibody persistence one year after three-dose primary
vaccination and booster immune response during the second year of life for a fully liquid …

From May, 1990, a new schedule of immunisation against diphtheria, tetanus, and pertussis
(at 2, 3, and 4 months) replaced the previous more widely spaced schedule. A report that …

BACKGROUND: Tdap is recommended for health care personnel (HCP) aged< 65 years
who received tetanus diphtheria or tetanus toxoid immunization (Td/TT)≥ 2 years earlier …